Rapid-Deployment Aortic Valve Replacement in a Real-World All-Comers Population

Area of Science:

• Cardiovascular Surgery
• Medical Devices
• Bioprosthetic Valves

Background:

• Evaluating mid-term outcomes of rapid-deployment aortic valve replacement (AVR).
• Focus on the use of the Edwards Intuity device in a real-world patient cohort.

Purpose of the Study:

• To assess the clinical and hemodynamic performance of rapid-deployment AVR using Edwards Intuity.
• To determine survival rates and adverse event incidence in patients undergoing this procedure.

Main Methods:

• A total of 215 patients underwent rapid-deployment AVR with Edwards Intuity.
• Follow-up duration was a median of 22 months, assessing overall survival and major adverse cardiac events.
• Early and 1-year hemodynamic performance of the bioprosthetic valve was evaluated.

Main Results:

• The study included patients with bicuspid valves, aortic regurgitation, and infective endocarditis.
• Overall survival at 3 years was 92.3% with an operative mortality of 2.8%.
• Excellent early and 1-year hemodynamic results were observed, with low mean pressure gradients.

Conclusions:

• Rapid-deployment AVR with Edwards Intuity is effective for diverse patient populations and indications.
• The procedure demonstrates excellent clinical and hemodynamic outcomes in real-world settings.
• The Edwards Intuity device is a viable option for complex aortic valve disease.